Literature DB >> 23127112

Insulin resistance and cardiovascular risk factors in women with PCOS who have normal glucose tolerance test.

Ismail Cem Yildir1, Faruk Kutluturk, Turker Tasliyurt, Berna Murat Yelken, Berat Acu, Murat Beyhan, Unal Erkorkmaz, Abdulkerim Yilmaz.   

Abstract

INTRODUCTION: We aimed to determine the insulin resistance in women with PCOS patients who have normal oral glucose tolerance test (OGTT) and to evaluate cardiovascular risk by measuring C-reactive protein (CRP) and carotid intimae-media thickness (CIMT).
METHODS: A total of 34 patients and age and body mass matched 20 healthy control subjects were included to this prospective study. Both of patients and control groups were consisted of normal oral glucose tolerance test. Insulin resistance (IR) was estimated using HOMA-IR method. CRP, lipid and hormone levels were measured. CIMT was measured by Carotid Artery B-Mode ultrasonography.
RESULTS: There was no significant difference between patients and controls in BMI, and waist circumference, lipid, TSH, LH, FSH, estradiol, and prolactin levels. Serum insulin, testosterone, DHEAS, ferritin levels and HOMA values were significantly higher in patient group. We found that 64.7% (n = 22/34) patients with PCOS had insulin resistance. Both of CIMT and CRP levels were significantly higher in the PCOS patients had BMI over 25 kg/m². CRP levels was significantly higher in the PCOS patients had waist circumference greater than 80 cm.
CONCLUSION: We found insulin resistance in the women with PCOS even if OGTT was normal. Our data were similar to literature, the women with PCOS have increased risk of premature atherosclerosis and metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23127112     DOI: 10.3109/09513590.2012.730573

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  8 in total

Review 1.  Targets to treat metabolic syndrome in polycystic ovary syndrome.

Authors:  Shruthi Mahalingaiah; Evanthia Diamanti-Kandarakis
Journal:  Expert Opin Ther Targets       Date:  2015-10-21       Impact factor: 6.902

2.  Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model.

Authors:  M Kupreeva; A Diane; R Lehner; R Watts; M Ghosh; S Proctor; D Vine
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-08-28       Impact factor: 4.310

Review 3.  Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome.

Authors:  Krystallenia I Alexandraki; Eleni A Kandaraki; Kalliopi-Anna Poulia; Christina Piperi; Eirini Papadimitriou; Theodoros G Papaioannou
Journal:  touchREV Endocrinol       Date:  2021-04-28

4.  The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis.

Authors:  Shaimaa Aboeldalyl; Cathryn James; Emaduldin Seyam; Emad Moussa Ibrahim; Hossam El-Din Shawki; Saad Amer
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

Review 5.  Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19.

Authors:  Ioannis Ilias; Spyridon Goulas; Lina Zabuliene
Journal:  World J Clin Cases       Date:  2021-04-26       Impact factor: 1.337

6.  Can Amlodipine Improve the Pre-ovulatory Follicle Blood Flow in Women with Polycystic Ovarian Syndrome?

Authors:  Doaa El Faham; Khaled Ali; Adel Salah El Din; Mamdouh Bibars; Osama Azmy
Journal:  J Reprod Infertil       Date:  2019 Apr-Jun

7.  The Association Between Serum Ferritin Concentration and Visceral Adiposity Estimated by Whole-Body DXA Scan in Women With Polycystic Ovary Syndrome.

Authors:  Agnieszka Adamska; Agnieszka Łebkowska; Anna Krentowska; Marcin Adamski; Irina Kowalska
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-08       Impact factor: 5.555

8.  Preparatory training attenuates drastic response of the insulin-like growth factor binding protein 1 at the point of maximal oxygen consumption in handball players.

Authors:  Olgica Nedić; Miloš Šunderić; Goran Miljuš; Zoran Valdevit; Vladimir Jakovljević; Marija Glibetić; Vesna Vučić
Journal:  J Sport Health Sci       Date:  2016-01-21       Impact factor: 7.179

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.